News
A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...
US pharma major Eli Lilly (NYSE: LLY) yesterday announced executive leadership transitions that will further enhance the ...
Skye Bioscience Inc (SKYE) reports significant advancements in clinical trials and a strong financial position, despite ...
NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.
Ooops... Something went wrong while loading this page.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...
14h
Us Weekly on MSNThe federal ban on generic GLP-1 starts this month. Here's what you can doIf you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...
The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).
Enhertu delivered a phase 3 trial win in early-stage breast cancer. Takeda spotlighted three late-stage readouts as a ...
For the first time in his career, the USA’s Boyd Martin has claimed the top spot in the FEI Eventing World Athlete Rankings after climbing from the 10th position in just one month with a tally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results